| Oct 7 |
Liquidia Shares Jump After US Supreme Court Rejects United Therapeutics' Appeal in Patent Dispute
|
| Oct 7 |
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
|
| Oct 7 |
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent
|
| Oct 7 |
Liquidia jumps as Supreme Court rejects United Therapeutics request for appeal in Tyvaso patent dispute
|
| Oct 2 |
Liquidia expands licensing deal with Pharmosa for lung therapy
|
| Oct 2 |
Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)
|
| Sep 30 |
Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting
|
| Sep 17 |
Travere (TVTX) Soars 5.9%: Is Further Upside Left in the Stock?
|
| Sep 16 |
Liquidia Says United Therapeutics' Interference Found by US Court to Have Caused Losses of Over $137 Million
|
| Sep 16 |
With 38% ownership in Liquidia Corporation (NASDAQ:LQDA), institutional investors have a lot riding on the business
|
